Israel to offer Pfizer booster shot against 19 to the over-60s



* Israel was a world leader in vaccine rollout

* Infections have spiked due to Delta variant

* Booster campaign to start on Sunday, reports say

By Jeffrey Heller

JERUSALEM, July 29 (Reuters) - Israel will begin offering a third shot of the Pfizer PFE.N /BioNTech 22UAY.DE COVID-19 vaccine to people aged over 60, a world first in efforts to slow the spread of the highly contagious Delta variant, a healthcare provider and Israeli media said on Thursday.

Those eligible will be able to get the booster shot starting on Sunday as long as they received their second dose more than five months ago, Maccabi Healthcare Services said in a statement that confirmed reports on Channel 13 TV and Kan public radio.

Israel was a world leader in the vaccination rollout, with many seniors getting their shots in December, January and February as they were regarded as the most vulnerable sector of the population.

But since the emergence of the Delta variant, the health ministry has twice reported a drop in the vaccine's efficacy against infection and a slight decrease in its protection against severe disease.

The booster campaign, due to be launched by Prime Minister Naftali Bennett at a news conference later in the day, will effectively turn Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration (FDA).

Pfizer said on Wednesday it believes people need the additional dose to keep protection against the coronavirus high. The company says it could apply for U.S. emergency authorization for booster shots as early as August.

A panel of Israeli vaccination experts advising the health ministry gave approval for the campaign late on Wednesday.

Maccabi, one of Israel's largest healthcare providers, said in its statement that eligible patients were welcome to schedule their vaccination appointment via the Internet or its call centre.

Last week, the health ministry estimated the Pfizer vaccine was only 41% effective at halting symptomatic infections over the past month. Protection against severe disease remained strong at 91%.

Some experts have criticised the ministry's analysis because of possible bias that could be skewing the data. Others said Israel should wait a little longer to receive more information about the safety and effectiveness of a third shot.

Around 57% of Israel's 9.3 million population has been vaccinated. Around 160 people are hospitalised with severe symptoms and daily new infections have spiked to more than 2,000, up from a handful of cases per day a few months ago.

The cabinet is hoping that the vaccines will allow it to avoid costly lockdowns by protecting those most vulnerable from severe illness.


Additional reporting by Dan Williams and Rami Ayyub; Editing by Mike Harrison and Mark Heinrich

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示: 您的資金存在風險。杠杆商品可能不適合所有客戶。 請詳細閱讀我們的風險聲明